These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A review of fecal microbiota, live-jslm for the prevention of recurrent Clostridioides difficile infection. Hunt A; Drwiega E; Wang Y; Danziger L Am J Health Syst Pharm; 2024 Jul; 81(15):e402-e411. PubMed ID: 38470061 [TBL] [Abstract][Full Text] [Related]
25. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure. Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961 [TBL] [Abstract][Full Text] [Related]
26. An Infectious Diseases Perspective on Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children. Cotter JM; Nicholson MR; Kociolek LK J Pediatric Infect Dis Soc; 2019 Dec; 8(6):580-584. PubMed ID: 31550348 [TBL] [Abstract][Full Text] [Related]
27. Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent Wei S; Bahl MI; Baunwall SMD; Dahlerup JF; Hvas CL; Licht TR Gut Microbes; 2022; 14(1):2084306. PubMed ID: 36519447 [TBL] [Abstract][Full Text] [Related]
28. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis. Cappetto CM Am J Health Syst Pharm; 2021 Jul; 78(15):1374-1381. PubMed ID: 33851215 [TBL] [Abstract][Full Text] [Related]
29. Fecal microbiota transplant for C. difficile infection: Just say yes. Cammarota G; Gallo A; Bibbò S Anaerobe; 2019 Dec; 60():102109. PubMed ID: 31644957 [TBL] [Abstract][Full Text] [Related]
30. Fecal Microbiota Transplantation for Treatment of Severe Clostridioides difficile Colitis in a Pediatric Patient With Non-Hodgkin Lymphoma. Sabus A; Merrow M; Heiden A; Boster J; Koo J; Franklin ARK J Pediatr Hematol Oncol; 2021 Aug; 43(6):e897-e899. PubMed ID: 33273413 [TBL] [Abstract][Full Text] [Related]
31. Fecal transplant clinical trials for Khanna S Future Microbiol; 2020 Jun; 15():709-712. PubMed ID: 32677453 [TBL] [Abstract][Full Text] [Related]
32. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis? Tang G; Yin W; Liu W Diagn Microbiol Infect Dis; 2017 Aug; 88(4):322-329. PubMed ID: 28602517 [TBL] [Abstract][Full Text] [Related]
33. Recurrent Clostridioides difficile Infection Is Associated With Impaired T Helper Type 17 Immunity to C difficile Toxin B. Cook L; Rees WD; Wong MQ; Kwok WW; Levings MK; Steiner TS Gastroenterology; 2021 Mar; 160(4):1410-1413.e4. PubMed ID: 33253683 [No Abstract] [Full Text] [Related]
34. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. Cheng YW; Phelps E; Ganapini V; Khan N; Ouyang F; Xu H; Khanna S; Tariq R; Friedman-Moraco RJ; Woodworth MH; Dhere T; Kraft CS; Kao D; Smith J; Le L; El-Nachef N; Kaur N; Kowsika S; Ehrlich A; Smith M; Safdar N; Misch EA; Allegretti JR; Flynn A; Kassam Z; Sharfuddin A; Vuppalanchi R; Fischer M Am J Transplant; 2019 Feb; 19(2):501-511. PubMed ID: 30085388 [TBL] [Abstract][Full Text] [Related]